ALK and lung cancer: A computational study revealed the allosteric effect of ALK F1174C mutation to ceritinib in lung cancer, and this is due to mutation affecting the interaction between ceritinib and the P-loop by changing the conformational dynamics of the P-loop and causing it to shift upward from the ATP-binding site (Ni et al., 2016).